Ewald Anger
Joined as CEO in 2007
Previously at VIASYS Healthcare as Marketing Manager for sleep medicine disorders with global responsibility for the marketing of all sleep diagnostic and sleep therapy products (1999 – 2007)
Since 1990 at Erich Jaeger GmbH, in 1999 acquired by Thermo Electron, the predecessor of VIASYS Healthcare
Extensive experience with worldwide product launches (e.g. 4 therapy systems and 2 PSG systems)
Significant participation in evaluations of M&A projects
Technical studies in information technology and degree – “The Science and Art of Marketing Analysis and Brand Planning”
Helene Zinsmeister
Anand Sampath
Chairman of the supervisory board: Tom Mc Clenahan
Supervisory Board Members: Bilal Muhsin, Micah Young
Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers & Wilkins, Denon, Marantz, and Polk Audio. Our mission is to improve life, improve patient outcomes, and reduce the cost of care. Masimo SET Measure-through Motion and Low Perfusion pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies. Masimo SET has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates, improve CCHD screening in newborns, and, when used for continuous monitoring with Masimo Patient SafetyNet in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs. Masimo SET is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world, and is the primary pulse oximetry at 9 of the top 10 hospitals as ranked in the 2022-23 U.S. News and World Report Best Hospitals Honor Roll.
In March 2020 acquired the TNI medical AG as a part of their company portfolio.